Delivery Order SPE2DR25D2005-SPE2DR26FF1Z2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dexamethasone 4 mg/ml vials with a contract ceiling value of $1,481.64. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by January 28, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/ml vials, with a ceiling value of $12,540.76 and a firm fixed-price structure. The award was made on January 15, 2026, with an ultimate completion date of January 16, 2026, and represents a non-set-aside, competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,643.44 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 4 mg/mL vials, with an ultimate completion date of December 19, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $6,707.89 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/mL in vial form, with an ultimate completion date of November 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,828.32 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 4 mg/ml vials. This firm fixed-price delivery order was competitively awarded without set-aside designations and is scheduled for completion by January 22, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and fulfills this order through its corporate...
- The Defense Logistics Agency awarded a $1,139.69 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dexamethasone 120 mg/30 ml vials on January 23, 2026, with an ultimate completion date of January 26, 2026. This non-set-aside award was competitively procured and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,069.28 to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 ml vials on December 16, 2025, with completion scheduled for December 17, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical supply vehicle running through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,568.18 to Amerisourcebergen Drug Corp for the supply of Dexamethasone 120 mg/30 ml vials on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,778.44 to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Dexamethasone 20 mg/5 mL vials (5 mL quantity). This is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,259.53 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Dexamethasone 4 mg/mL vials. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FF1Z2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,207.51 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 4 mg/mL vials. This firm fixed-price, non-set-aside contract was awarded on January 28, 2026, with an ultimate completion date of January 29, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. This delivery order represents a small-value transaction typical of the routine pharmaceutical procurement conducted through the DLA's prime vendor model. Dexamethasone, a corticosteroid commonly used in military and federal medical settings for inflammation and immune suppression, is a critical commodity within the military healthcare supply chain. AmerisourceBergen Drug Corp's parent company, Cencora, Inc., maintains the master IDC with DLA and holds an additional $999,999,999.00 indefinite delivery contract through December 31, 2031, demonstrating the company's significant role in federal pharmaceutical distribution and its established capability to meet government medical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/27/26 |